NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=150283&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=150280&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=150260&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Solaris Energy Infrastructure, Inc. (NYSE:SEI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/solaris-energy-infrastructure-inc-lawsuit-submission-form?prid=150258&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=150254&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

SINGAPORE, SG / ACCESS Newswire / May 26, 2025 / Singapore-based asset management firm Burghley Capital have identified strong resilience in Singapore’s technology spending over the past 12 months, with projections indicating it will reach USD $19 billion (SGD $25.5 billion) by the end of 2025. Despite economic uncertainties and rising trade tensions in the

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=150252&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / Marlboro-Chesterfield Pathology, P.C. recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of several individuals. This data breach has led to concerns over the security of sensitive personal and protected health information entrusted toMarlboro-Chesterfield Pathology. WHAT’S

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / Andy Frain Services, Inc.recently disclosed that it suffered a data breach that compromised the sensitive personal data of individuals. This data breach has led to concerns over the security of sensitive personal and protected health information entrusted to Andy Frain Services. WHAT’S THIS ABOUT?

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your SoundHound AI, Inc. (NASDAQ:SOUN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/soundhound-ai-inc-lawsuit-submission-form?prid=150243&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or